Boulanger Luce, Girard Nathalie, Strecko Julie, Gaudreau Pierrette
Laboratory of Neuroendocrinology of Aging, Department of Medicine, CHUM Research Center, Notre-Dame Hospital, University of Montreal, 1560 East Sherbrooke Street, Que., H2L 4M1, Montreal, Canada.
Peptides. 2002 Jun;23(6):1187-94. doi: 10.1016/s0196-9781(02)00029-3.
Receptor binding analysis was performed in the renal medulla from 2-month-old rats, an extrapituitary tissue containing the highest level of GHRH receptor mRNA. At 4 degrees C, in the presence of a cocktail of protease inhibitors, binding of [125I-Tyr(10)]hGHRH (1-44)NH(2) to medullary homogenates was specific, time-dependent, reversible and saturable (K(d): 28 nM; B(max): 30 fmol/mgprot.). In these experimental conditions, no change of binding parameters could be detected in the course of aging. The structure-affinity profile was different in the two tissues and chemical cross-linking revealed the presence of 65-, 55- and 38-kDa 125I-GHRH-labeled complexes in the renal medulla compared to 65-, 47- and 28-kDa radioactive complexes in the anterior pituitary. It is suggested that GHRH binding sites, and possibly the receptor, may be different in the two tissues.
在2月龄大鼠的肾髓质中进行了受体结合分析,肾髓质是一种垂体外组织,其生长激素释放激素(GHRH)受体mRNA水平最高。在4℃下,在蛋白酶抑制剂混合物存在的情况下,[125I-酪氨酸(10)]人GHRH(1-44)NH2与髓质匀浆的结合具有特异性、时间依赖性、可逆性和饱和性(解离常数K(d):28 nM;最大结合容量B(max):30 fmol/mg蛋白)。在这些实验条件下,衰老过程中未检测到结合参数的变化。两种组织中的结构-亲和力图谱不同,化学交联显示肾髓质中存在65 kDa、55 kDa和38 kDa的125I-GHRH标记复合物,而垂体前叶中存在65 kDa、47 kDa和28 kDa的放射性复合物。提示两种组织中的GHRH结合位点以及可能的受体可能不同。